en · de · es
melanotan-2-notes.peptides1126.com › Data › Melanotan-2 Structure And Receptor Pharmacology — Questions and Answers

Melanotan-2 Structure And Receptor Pharmacology — Questions and Answers

By Editorial Desk · published 2025-10-09 · last reviewed 2025-11-09 · Data

alpha-MSH analogue raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-11-09. Anything still debated is marked as such rather than presented as settled.

Melanotan-2 Structure and Receptor Pharmacology

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Chemistry and Receptor Pharmacology

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Free base; salt forms add to total mass
Molecular massAbout 1024 daltonsCalculated for the free base
Structural classCyclic heptapeptideContains D-phenylalanine and norleucine
Parent hormoneAlpha-melanocyte-stimulating hormoneEndogenous tridecapeptide of 13 residues
Receptor profileNon-selective melanocortin agonistInteracts with MC1R, MC3R, MC4R and MC5R

Identity and Chemical Background

Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.

The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.

Related pages on this site

Origins and Research Status

Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.

The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.

Melanotan-2 Identity and Receptor Pharmacology

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Reference notes

amplicon Any DNA or RNA sequence or fragment that is the source and/or product of an amplification reaction. The term is most frequently used to describe the numerous copied fragments that are the products of the polymerase chain reaction or ligase chain reaction, though it may also refer to sequences that are amplified naturally within a genome, e.g. by gene duplication.

By the 1880s, Knoxville had a murder rate that was higher than Los Angeles's murder rate in the 1990s. Journalist Jack Neely points out that "saloons, whorehouses, cocaine parlors, gambling dens, and poolrooms" lined Central Street from the railroad tracks to the river. High-profile shootouts were not uncommon, the most well-known being the Mabry-O'Connor shootout on Gay Street, which left banker Thomas O'Connor, businessman Joseph Mabry, and Mabry's son, dead in 1882. In 1901, Kid Curry, a member of Butch Cassidy's Wild Bunch, shot and killed two police officers at Ike Jones's Bar on Central. The Kid Curry shooting helped fuel calls for citywide prohibition, which was enacted in 1907. After World War I, the United States suffered a major economic recession, and Knoxville, like many other cities, experienced an influx of migrants moving to the city in search of work. Racial tensions heightened as poor whites and blacks competed for the few available jobs, and both the Ku Klux Klan and the National Association for the Advancement of Colored People (NAACP) opened chapters in the city. On August 30, 1919, these tensions erupted in the so-called Riot of 1919, the city's worst race riot, which shattered the city's vision of itself as a racially tolerant Southern town.

=== Agmatine and polyamines === The decarboxylation of arginine by arginine decarboxylase produces agmatine, which functions as a neuromodulator and serves as an alternative precursor for the synthesis of polyamines. In mammals, these are essential for various post-translational modifications, including those involving histones. Agmatine can be converted into N-carbamoylputrescine and subsequently into putrescine. Alternatively, putrescine is formed by decarboxylation of ornithine. Putrescine can then be converted into spermidine and subsequently into spermine, the other polyamines. The relative contributions of agmatine and ornithine to putrescine formation are not yet fully understood. Various plant alkaloids, such as nicotine and the tropane alkaloids cocaine, hyoscyamine, and scopolamine, are synthesized in plants from putrescine. This compound is usually derived from ornithine but can also originate from arginine. Likewise, homospermidine, a precursor of the pyrrolizidine alkaloids (e.g., senecionin), is formed from arginine or ornithine via putrescine. Both arginine and ornithine can be converted into putrescine in bacteria. The pathway utilized depends on whether arginine is converted into ornithine or metabolized via alternative routes, as well as on its availability. Prokaryotes possessing arginine decarboxylase include enterobacteria, mycobacteria, and representatives of Aeromonas and Pseudomonas.

Sources: en.wikipedia.org

Notes from published material

=== Field management === As mentioned, permissive hypotension (restrictive fluid therapy) is unwise. Careful fluid overload and administration of intravenous sodium bicarbonate is wise, especially if the crushing weight is on the patient for more than four hours, but often if it persists more than one hour. The San Francisco emergency services protocol calls for a basic adult dose of a 2 L bolus of normal saline followed by 500 mL/h, limited for "pediatric patients and patients with history of cardiac or renal dysfunction". Use of a tourniquet can stall the life-threatening consequences of a crush related injury and can be a second option if the person cannot immediately have the fluids that were lost be medically replaced back into the body. Tourniquet measures should be taken if the person has been trapped for more than two hours.

=== Spring 1945 offensive in Italy === Kesselring's forces in Italy retained their formidable defensive positions in the northern Apennines in March 1945. The 6th Division rejoined the line in early April, shortly before the Allies launched their spring 1945 offensive, Operation Grapeshot. The units including Rhodesians took up positions opposite Monte Sole, Monte Abelle and Monte Caprara. The Rhodesian 25-pounder guns were posted slightly forward of their former positions, and B (Rhodesia) Squadron, Prince Alfred's Guard, moved to Grizzana. The Special Service Battalion provided armoured support to the 13th South African Motorised Brigade. The South Africans and Rhodesians launched a two-pronged assault on the German positions over the road to Bologna at 22:30 on 15 April 1945. The Cape Town Highlanders' advance up the steep cliffs of Monte Sole was obstructed by a German minefield that guarded the peak. The Rhodesian officer commanding the leading platoon, Second Lieutenant G B Mollett, took a section of men and dashed through the minefield to the summit; for this he later received the Distinguished Service Order. Hand-to-hand fighting on Monte Sole continued until dawn, when the Germans withdrew. The Witwatersrand Rifles meanwhile took Monte Caprara. The Cape Town Highlanders took Monte Abelle late on 16 April, advancing under heavy artillery fire to the summit before clearing it of Germans. The regiment lost 31 killed and 76 wounded during these actions, including three Rhodesians killed and three wounded.

An intraarticular fracture is a bone fracture that typically runs parallel to the joint surface in which the break crosses into the surface of a joint, through the articular cartilage. This always results in damage to the cartilage, an area of limited healing capability. Compared to extraarticular fractures, intraarticular have a higher risk for developing long-term complications, such as posttraumatic osteoarthritis. For the majority of these fractures, anatomic reduction is vital to maintain the integrity of the joint surface.

Sources: en.wikipedia.org

Further detail

The bill reduced the number of elected trustees to a minimum of 12, changed the responsibilities of trustees, and introduced the position of school board chief executive officer. To reduce student absenteeism among secondary school students, the bill makes attendance and participation part of students' final marks and introduces written final exams.

== Developments and Milestones == Breakthrough Device Designation In October 2025, the company's ExomeDx and GenomeDx testing was granted FDA Breakthrough Device designation for use in diagnosing symptomatic patients with life-threatening diseases or genetic disorders. Acquisition of Fabric Genomics In April 2025, GeneDx announced the acquisition of Fabric Genomics, an AI-powered genomic interpretation company. The transaction closed in May 2025 for up to $33 million in cash at closing, with total consideration potentially reaching $51 million upon achievement of certain milestones. Financial Performance In 2024, GeneDx reported revenue of $302.3 million, representing 56% year-over-year growth, and announced its first profitable quarter in October 2024. For full-year 2025, the company reported revenue of approximately $427 million. Genomic Newborn Screening GeneDx is a sequencing and interpretation partner in the GUARDIAN (Genomic Uniform-screening Against Rare Diseases In All Newborns) study, a research initiative examining whether whole genome sequencing can improve health outcomes for newborns. The study is conducted in collaboration with Columbia University, NewYork-Presbyterian, the New York State Department of Health, and Illumina. Results from the study were published in JAMA in October 2024, reporting a 3.7% screen-positive rate among enrolled newborns. 92% of true-positives would not have been detected using standard newborn screening technology.

== Lipid == Lipids (oleaginous) are chiefly fatty acid esters, and are the basic building blocks of biological membranes. Another biological role is energy storage (e.g., triglycerides). Most lipids consist of a polar or hydrophilic head (typically glycerol) and one to three non polar or hydrophobic fatty acid tails, and therefore they are amphiphilic. Fatty acids consist of unbranched chains of carbon atoms that are connected by single bonds alone (saturated fatty acids) or by both single and double bonds (unsaturated fatty acids). The chains are usually 14–24 carbon groups long, but it is always an even number. For lipids present in biological membranes, the hydrophilic head is from one of three classes:

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan-2 approved for medical use?

No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.

How does melanotan-2 differ from melanotan-1?

Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.

What is the connection to alpha-MSH?

Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

Network